ShihShen Lee - Medigen Vaccine Exec Unit
| 6547 Stock | TWD 49.05 0.65 1.31% |
Insider
ShihShen Lee is Exec Unit of Medigen Vaccine Biologics
| Phone | 886 2 7745 0830 |
| Web | https://www.medigenvac.com |
Medigen Vaccine Management Efficiency
The company has return on total asset (ROA) of 0.0209 % which means that it generated a profit of $0.0209 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0662 %, meaning that it generated $0.0662 on every $100 dollars invested by stockholders. Medigen Vaccine's management efficiency ratios could be used to measure how well Medigen Vaccine manages its routine affairs as well as how well it operates its assets and liabilities.Medigen Vaccine Biologics has accumulated 286.54 M in total debt with debt to equity ratio (D/E) of 0.06, which may suggest the company is not taking enough advantage from borrowing. Medigen Vaccine Biologics has a current ratio of 9.53, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Medigen Vaccine until it has trouble settling it off, either with new capital or with free cash flow. So, Medigen Vaccine's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Medigen Vaccine Biologics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Medigen to invest in growth at high rates of return. When we think about Medigen Vaccine's use of debt, we should always consider it together with cash and equity.
Medigen Vaccine Biologics Corporation, a biotechnology drug company, focuses on the development and production of vaccines and biologics in Taiwan and internationally. Medigen Vaccine Biologics Corporation is a subsidiary of Medigen Biotechnology Corp. MEDIGEN VACCINE operates under Biotechnology classification in Taiwan and is traded on Taiwan OTC Exchange. Medigen Vaccine Biologics (6547) is traded on Taiwan OTC Exchange in Taiwan and employs 16 people. Management Performance
| Return On Equity | 0.0662 | |||
| Return On Asset | 0.0209 |
Medigen Vaccine Biologics Leadership Team
Elected by the shareholders, the Medigen Vaccine's board of directors comprises two types of representatives: Medigen Vaccine inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medigen. The board's role is to monitor Medigen Vaccine's management team and ensure that shareholders' interests are well served. Medigen Vaccine's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medigen Vaccine's outside directors are responsible for providing unbiased perspectives on the board's policies.
| ShihShen Lee, Exec Unit | ||
| Yuping Yang, Manager of Finance & Accounting Management Division |
Medigen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medigen Vaccine a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0662 | |||
| Return On Asset | 0.0209 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.09 % | |||
| Current Valuation | 24.78 B | |||
| Shares Outstanding | 327.2 M | |||
| Shares Owned By Insiders | 27.99 % | |||
| Shares Owned By Institutions | 5.13 % | |||
| Price To Earning | 34.63 X | |||
| Price To Book | 4.71 X |
Pair Trading with Medigen Vaccine
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Medigen Vaccine position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medigen Vaccine will appreciate offsetting losses from the drop in the long position's value.Moving against Medigen Stock
| 0.43 | 3533 | Lotes | PairCorr |
| 0.41 | 4966 | Parade Technologies Earnings Call This Week | PairCorr |
| 0.39 | 2820 | China Bills Finance | PairCorr |
The ability to find closely correlated positions to Medigen Vaccine could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Medigen Vaccine when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Medigen Vaccine - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Medigen Vaccine Biologics to buy it.
The correlation of Medigen Vaccine is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Medigen Vaccine moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Medigen Vaccine Biologics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Medigen Vaccine can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Medigen Stock Analysis
When running Medigen Vaccine's price analysis, check to measure Medigen Vaccine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medigen Vaccine is operating at the current time. Most of Medigen Vaccine's value examination focuses on studying past and present price action to predict the probability of Medigen Vaccine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medigen Vaccine's price. Additionally, you may evaluate how the addition of Medigen Vaccine to your portfolios can decrease your overall portfolio volatility.